摘要
针对我国新修订药品GMP中对药品注册与上市生产工艺保持一致性的要求,对企业目前所存在的缺陷和不足进行分析探讨,为药品生产企业顺利实施新修订版本GMP提供参考。
This paper discussed and analyzed the defects and problems existed in the drug enterprises according to the requirements of newly revised GMP in the aspect of keeping consistency of production technology used for drug registration approval and for manufacturing of products to be marketed,so as to provide references for implementation of the newly revised GMP smoothly.
出处
《中国执业药师》
CAS
2011年第4期39-40,共2页
China Licensed Pharmacist
